• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国儿童普拉德-威利综合征诊断与管理建议。

Recommendations for the diagnosis and management of childhood Prader-Willi syndrome in China.

机构信息

Children's Hospital of Zhejiang University School of Medicine, No. 3333 Binsheng Road, Hangzhou, 310003, China.

Children's Hospital of Fudan University, Shanghai, China.

出版信息

Orphanet J Rare Dis. 2022 Jun 13;17(1):221. doi: 10.1186/s13023-022-02302-z.

DOI:10.1186/s13023-022-02302-z
PMID:35698200
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9195308/
Abstract

Prader-Willi syndrome (PWS) is a complex and multisystem neurobehavioral disease, which is caused by the lack of expression of paternally inherited imprinted genes on chromosome15q11.2-q13.1. The clinical manifestations of PWS vary with age. It is characterized by severe hypotonia with poor suck and feeding difficulties in the early infancy, followed by overeating in late infancy or early childhood and progressive development of morbid obesity unless the diet is externally controlled. Compared to Western PWS patients, Chinese patients have a higher ratio of deletion type. Although some rare disease networks, including PWS Cooperation Group of Rare Diseases Branch of Chinese Pediatric Society, Zhejiang Expert Group for PWS, were established recently, misdiagnosis, missed diagnosis and inappropriate intervention were usually noted in China. Therefore, there is an urgent need for an integrated multidisciplinary approach to facilitate early diagnosis and optimize management to improve quality of life, prevent complications, and prolong life expectancy. Our purpose is to evaluate the current literature and evidences on diagnosis and management of PWS in order to provide evidence-based guidelines for this disease, specially from China.

摘要

普拉德-威利综合征(PWS)是一种复杂的多系统神经行为疾病,由 15q11.2-q13.1 染色体上父源印迹基因表达缺失引起。PWS 的临床表现随年龄而变化。其特征为婴儿早期严重的肌张力低下,吸吮和喂养困难,随后在婴儿后期或幼儿期出现暴食,并逐渐发展为病态肥胖,除非进行饮食的外部控制。与西方 PWS 患者相比,中国患者的缺失型比例更高。尽管最近成立了一些罕见病网络,包括中国儿科协会罕见病分会 PWS 协作组、浙江 PWS 专家组,但在中国,通常存在误诊、漏诊和不当干预的情况。因此,迫切需要采用综合多学科方法,以促进早期诊断和优化管理,从而提高生活质量,预防并发症,并延长预期寿命。我们的目的是评估当前关于 PWS 的诊断和管理的文献和证据,以便为该疾病提供循证指南,特别是来自中国的指南。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecac/9195308/bcc85b79bf37/13023_2022_2302_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecac/9195308/bcc85b79bf37/13023_2022_2302_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecac/9195308/bcc85b79bf37/13023_2022_2302_Fig1_HTML.jpg

相似文献

1
Recommendations for the diagnosis and management of childhood Prader-Willi syndrome in China.中国儿童普拉德-威利综合征诊断与管理建议。
Orphanet J Rare Dis. 2022 Jun 13;17(1):221. doi: 10.1186/s13023-022-02302-z.
2
The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria.普拉德-威利综合征临床诊断标准的目的变化及修订标准建议
Pediatrics. 2001 Nov;108(5):E92. doi: 10.1542/peds.108.5.e92.
3
Prader-Willi syndrome patient with atypical phenotypes caused by mosaic deletion in the paternal 15q11-q13 region: a case report.Prader-Willi 综合征患者存在父源 15q11-q13 区域镶嵌性缺失导致的非典型表型:一例病例报告。
Ital J Pediatr. 2022 Dec 29;48(1):204. doi: 10.1186/s13052-022-01398-0.
4
Case Report: Hepatic Adenomatosis in a Patient With Prader-Willi Syndrome.病例报告:普瑞德-威利综合征患者的肝腺瘤。
Front Endocrinol (Lausanne). 2022 Mar 9;13:826772. doi: 10.3389/fendo.2022.826772. eCollection 2022.
5
Systematic review of the clinical and genetic aspects of Prader-Willi syndrome.普拉德-威利综合征临床与遗传学方面的系统评价
Korean J Pediatr. 2011 Feb;54(2):55-63. doi: 10.3345/kjp.2011.54.2.55. Epub 2011 Feb 28.
6
[Clinical practice guidelines for Prader-Willi syndrome].[普拉德-威利综合征临床实践指南]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2020 Mar 10;37(3):318-323. doi: 10.3760/cma.j.issn.1003-9406.2020.03.016.
7
Prader-Willi syndrome.普拉德-威利综合征
Eur J Hum Genet. 2009 Jan;17(1):3-13. doi: 10.1038/ejhg.2008.165. Epub 2008 Sep 10.
8
Newborn screening for Prader-Willi syndrome is feasible: Early diagnosis for better outcomes.新生儿 Prader-Willi 综合征筛查可行:早期诊断可改善预后。
Am J Med Genet A. 2019 Jan;179(1):29-36. doi: 10.1002/ajmg.a.60681. Epub 2018 Dec 17.
9
[Care continuity for patients with Prader-Willi syndrome during transition from childhood to adulthood].普拉德-威利综合征患者从儿童期到成年期过渡期间的护理连续性
Nihon Rinsho. 2010 Jan;68(1):141-4.
10
Molecular diagnosis of Prader-Willi syndrome.普拉德-威利综合征的分子诊断
J Med Assoc Thai. 2003 Aug;86 Suppl 3:S510-6.

引用本文的文献

1
Molecular characterization of imprinting disorders: Beckwith-Wiedemann, Silver-Russell, and Prader-Willi syndromes in Egyptian patients.印记障碍的分子特征:埃及患者中的贝克威思-维德曼综合征、西尔弗-拉塞尔综合征和普拉德-威利综合征
BMC Pediatr. 2025 Jul 29;25(1):576. doi: 10.1186/s12887-025-05901-4.
2
The influence of genotype makeup on the effectiveness of growth hormone therapy in children with Prader-Willi syndrome.基因型构成对普拉德-威利综合征患儿生长激素治疗效果的影响。
BMC Pediatr. 2024 Oct 1;24(1):627. doi: 10.1186/s12887-024-05109-y.
3
[Early diagnosis and intervention for prepubertal short stature children].

本文引用的文献

1
The Effects of Limosilactobacillus reuteri LR-99 Supplementation on Body Mass Index, Social Communication, Fine Motor Function, and Gut Microbiome Composition in Individuals with Prader-Willi Syndrome: a Randomized Double-Blinded Placebo-Controlled Trial.雷特氏乳杆菌 LR-99 补充剂对普拉德-威利综合征患者体重指数、社会交流、精细运动功能和肠道微生物组成的影响:一项随机、双盲、安慰剂对照试验。
Probiotics Antimicrob Proteins. 2021 Dec;13(6):1508-1520. doi: 10.1007/s12602-021-09800-9. Epub 2021 Jun 11.
2
[Analysis of the clinical perinatal characteristics of 226 patients with Prader-Willi syndrome in China].[中国226例普拉德-威利综合征患者围产期临床特征分析]
Zhonghua Er Ke Za Zhi. 2021 Jun 2;59(6):466-470. doi: 10.3760/cma.j.cn112140-20210203-00100.
3
[青春期前身材矮小儿童的早期诊断与干预]
Zhongguo Dang Dai Er Ke Za Zhi. 2024 Jun 15;26(6):553-558. doi: 10.7499/j.issn.1008-8830.2312103.
4
Complex Cardiovascular Morbidities in Prader-Willi Syndrome: A Multidisciplinary Approach.普拉德-威利综合征中的复杂心血管疾病:多学科方法
Cureus. 2024 Mar 20;16(3):e56591. doi: 10.7759/cureus.56591. eCollection 2024 Mar.
5
Evaluating the effect of recombinant human growth hormone treatment on sleep-related breathing disorders in toddlers with Prader-Willi syndrome: a one-year retrospective cohort study.评估重组人生长激素治疗对 Prader-Willi 综合征幼儿睡眠相关呼吸障碍的影响:一项为期一年的回顾性队列研究。
BMC Pediatr. 2024 Jan 10;24(1):32. doi: 10.1186/s12887-023-04513-0.
6
Early psychomotor development and growth hormone therapy in children with Prader-Willi syndrome: a review.普拉德-威利综合征患儿的早期精神运动发育与生长激素治疗:综述
Eur J Pediatr. 2024 Mar;183(3):1021-1036. doi: 10.1007/s00431-023-05327-z. Epub 2023 Nov 21.
7
Prader-Willi and Angelman Syndromes: Mechanisms and Management.普拉德-威利综合征和安吉尔曼综合征:发病机制与治疗
Appl Clin Genet. 2023 Apr 6;16:41-52. doi: 10.2147/TACG.S372708. eCollection 2023.
Prenatal diagnosis of a 15q11.2-q14 deletion of paternal origin associated with increased nuchal translucency, mosaicism for de novo multiple unbalanced translocations involving 15q11-q14, 5qter, 15qter, 17pter and 3qter and Prader-Willi syndrome.产前诊断提示父源 15q11.2-q14 缺失,伴有颈项透明层增厚,存在新发的多种不平衡易位的嵌合体,涉及 15q11-q14、5qter、15qter、17pter 和 3qter,以及普拉德-威利综合征。
Taiwan J Obstet Gynecol. 2021 Mar;60(2):335-340. doi: 10.1016/j.tjog.2021.01.012.
4
Oxytocin in young children with Prader-Willi syndrome: Results of a randomized, double-blind, placebo-controlled, crossover trial investigating 3 months of oxytocin.患有普拉德-威利综合征的幼儿的催产素:一项为期 3 个月的催产素随机、双盲、安慰剂对照、交叉试验的结果。
Clin Endocrinol (Oxf). 2021 May;94(5):774-785. doi: 10.1111/cen.14387. Epub 2020 Dec 21.
5
Intranasal oxytocin versus placebo for hyperphagia and repetitive behaviors in children with Prader-Willi Syndrome: A randomized controlled pilot trial.鼻腔内给予催产素与安慰剂治疗 Prader-Willi 综合征儿童的食欲过盛和重复行为:一项随机对照初步试验。
J Psychiatr Res. 2021 May;137:643-651. doi: 10.1016/j.jpsychires.2020.11.006. Epub 2020 Nov 4.
6
Sleep-disordered breathing and genetic findings in children with Prader-Willi syndrome in China.中国普拉德-威利综合征患儿的睡眠呼吸障碍与基因研究结果
Ann Transl Med. 2020 Aug;8(16):989. doi: 10.21037/atm-20-4475.
7
[Clinical screening and genetic diagnosis for Prader-Willi syndrome].普拉德-威利综合征的临床筛查与基因诊断
Zhongguo Dang Dai Er Ke Za Zhi. 2020 Sep;22(9):1001-1006. doi: 10.7499/j.issn.1008-8830.2003344.
8
The 10q26 Risk Haplotype of Age-Related Macular Degeneration Aggravates Subretinal Inflammation by Impairing Monocyte Elimination.年龄相关性黄斑变性的10q26风险单倍型通过损害单核细胞清除加重视网膜下炎症。
Immunity. 2020 Aug 18;53(2):429-441.e8. doi: 10.1016/j.immuni.2020.07.021.
9
[Application of various genetic techniques for the diagnosis of Prader-Willi syndrome].[多种基因技术在普拉德-威利综合征诊断中的应用]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2020 Aug 10;37(8):875-878. doi: 10.3760/cma.j.issn.1003-9406.2020.08.017.
10
A newborn screening pilot study using methylation-sensitive high resolution melting on dried blood spots to detect Prader-Willi and Angelman syndromes.利用甲基化敏感高分辨率熔解曲线分析干血斑对普拉德-威利和安格曼综合征进行新生儿筛查的初步研究。
Sci Rep. 2020 Aug 3;10(1):13026. doi: 10.1038/s41598-020-69750-0.